Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants
Marios Koutsakos, Wen Shi Lee, Arnold Reynaldi, et al.
Immunity (2022) Vol. 55, Iss. 7, pp. 1316-1326.e4
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Khadija Khan, Farina Karim, Yashica Ganga, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 156
SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses
Marios Koutsakos, Arnold Reynaldi, Wen Shi Lee, et al.
Immunity (2023) Vol. 56, Iss. 4, pp. 879-892.e4
Open Access | Times Cited: 78
Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection
Mark M. Painter, Timothy S. Johnston, Kendall A. Lundgreen, et al.
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1711-1724
Open Access | Times Cited: 69
Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants
Timothy S. Johnston, Shuk Hang Li, Mark M. Painter, et al.
Immunity (2024) Vol. 57, Iss. 4, pp. 912-925.e4
Open Access | Times Cited: 31
Prior vaccination prevents overactivation of innate immune responses during COVID-19 breakthrough infection
Leslie Chan, Kassandra Pinedo, Mikayla A. Stabile, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 783
Closed Access | Times Cited: 2
Heterogeneous SARS-CoV-2 kinetics due to variable timing and intensity of immune responses
Katherine Owens, Shadisadat Esmaeili, Joshua T. Schiffer
JCI Insight (2024) Vol. 9, Iss. 9
Open Access | Times Cited: 11
Covid-19: is omicron less lethal than delta?
Ramon Lorenzo‐Redondo, Egon A. Ozer, Judd F. Hultquist
BMJ (2022), pp. o1806-o1806
Open Access | Times Cited: 34
Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection
Wen Shi Lee, Hyon‐Xhi Tan, Arnold Reynaldi, et al.
Science Advances (2023) Vol. 9, Iss. 29
Open Access | Times Cited: 20
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium
Francesca Sperotto, Alba Gutiérrez‐Sacristán, Simran Makwana, et al.
EClinicalMedicine (2023) Vol. 64, pp. 102212-102212
Open Access | Times Cited: 17
Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans
Stephen J. Kent, Shiyao Li, Thakshila Amarasena, et al.
ACS Nano (2024)
Open Access | Times Cited: 5
Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong Kong
Runhong Zhou, Na Liu, Xin Li, et al.
The Lancet Regional Health - Western Pacific (2022) Vol. 32, pp. 100660-100660
Open Access | Times Cited: 23
Omicron variants breakthrough infection elicited higher specific memory immunity than third dose booster in healthy vaccinees
Pei Yu, Zijian Liu, Zhuoqi Zhu, et al.
Virologica Sinica (2023) Vol. 38, Iss. 2, pp. 233-243
Open Access | Times Cited: 12
Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants
Timothy S. Johnston, Shuk Hang Li, Mark M. Painter, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Australia’s COVID-19 vaccine journey: progress and future perspectives
James A. Triccas, Megan Steain
Microbiology Australia (2024)
Open Access | Times Cited: 4
SARS-CoV-2 breakthrough infections enhance T cell response magnitude, breadth, and epitope repertoire
Alison Tarke, Parham Ramezani-Rad, Tertuliano Alves Pereira Neto, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 6, pp. 101583-101583
Open Access | Times Cited: 4
Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants
Ebene R. Haycroft, Samantha K. Davis, Pradhipa Ramanathan, et al.
Medical Microbiology and Immunology (2023) Vol. 212, Iss. 4, pp. 291-305
Open Access | Times Cited: 11
Dissecting the Protective Effect of CD8+ T Cells in Response to SARS-CoV-2 mRNA Vaccination and the Potential Link with Lymph Node CD8+ T Cells
Mengfei Chen, Vanessa Venturi, C. Mee Ling Munier
Biology (2023) Vol. 12, Iss. 7, pp. 1035-1035
Open Access | Times Cited: 10
Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections
Kevin J. Selva, Pradhipa Ramanathan, Ebene R. Haycroft, et al.
JCI Insight (2023) Vol. 8, Iss. 18
Open Access | Times Cited: 10
Validation and Suitability Assessment of Multiplex Mesoscale Discovery Immunogenicity Assay for Establishing Serological Signatures Using Vaccinated, Non-vaccinated and Breakthrough SARS-COV-2 Infected Cases
Sushant Shengule, Shweta Alai, Sachin Bhandare, et al.
(2024)
Open Access | Times Cited: 2
Recapitulating memory B cell responses in a Lymphoid Organ-Chip to evaluate mRNA vaccine boosting strategies
Raphaël Jeger-Madiot, Delphine Planas, Isabelle Staropoli, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses
Karlijn van der Straten, Denise Guerra, Gius Kerster, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 8, pp. e1012453-e1012453
Open Access | Times Cited: 2
Antibody Fc receptor binding and T cell responses to homologous and heterologous immunization with inactivated or mRNA vaccines against SARS-CoV-2
Carolyn A. Cohen, Nancy Leung, Prathanporn Kaewpreedee, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection with early activation of memory T cells followed by production of potent neutralizing antibodies
Mark M. Painter, Timothy S. Johnston, Kendall A. Lundgreen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants
Junxiang Wang, Kaiyi Li, Xinyue Mei, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 11
Rational design of a booster vaccine against COVID-19 based on antigenic distance
Ye‐Fan Hu, Terrence Tsz‐Tai Yuen, Huarui Gong, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 8, pp. 1301-1316.e8
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top